Curcumin loaded NIPAAM/VP/PEG-A nanoparticles: Physicochemical and chemopreventive properties

Journal of Biomaterials Science, Polymer Edition

Volumn 24, Issue 5, 2013, Pages 574-588

  Salehi, Pezhman ^a   Makhoul, Georges ^a   Roy, Ranjan ^a   Malhotra, Meenakshi ^a   Mood, Zhoobin A ^a   Daniel, Sam J ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Curcumin; Drug delivery; N isopropylacrylamide; Nanoparticles; Solubility; Sustained drug release; Thermosensitive polymers

Indexed keywords

CURCUMIN; EPIDERMOID CARCINOMATA; HUMAN PROSTATE CANCER CELLS; N-ISOPROPYLACRYLAMIDES; OPTIMAL CONCENTRATION; POLYMERIC NANOPARTICLES; SUSTAINED DRUG RELEASE; THERMO-SENSITIVE POLYMER;

ACRYLIC MONOMERS; BIOMATERIALS; CELL CULTURE; CELLS; DRUG DELIVERY; DRUG PRODUCTS; FOURIER TRANSFORM INFRARED SPECTROSCOPY; NANOPARTICLES; POLYMERS; SOLUBILITY;

SYNTHESIS (CHEMICAL);

CURCUMIN; MACROGOL DERIVATIVE; NANOCARRIER; POLY(N ISOPROPYLACRYLAMIDE); POLYETHYLENE GLYCOL MONOACRYLATE; POVIDONE; UNCLASSIFIED DRUG; WATER; 2 PYRROLIDINONE; 2 PYRROLIDONE DERIVATIVE; 2-PYRROLIDONE; ACRYLAMIDE DERIVATIVE; ACRYLIC ACID DERIVATIVE; ANTINEOPLASTIC AGENT; N ISOPROPYLACRYLAMIDE; N-ISOPROPYLACRYLAMIDE; NANOPARTICLE;

ARTICLE; CANCER CELL; CARCINOMA CELL; CELL DEATH; CELL VIABILITY ASSAY; CONTROLLED CLINICAL TRIAL (TOPIC); HYDRODYNAMICS; IC 50; IN VITRO STUDY; INFRARED SPECTROSCOPY; PARTICLE SIZE; PH; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; PROSTATE CANCER; SOLUBILITY; SQUAMOUS CELL CARCINOMA; SUSTAINED DRUG RELEASE; TEMPERATURE; ZETA POTENTIAL; CELL SURVIVAL; CHEMISTRY; DELAYED RELEASE FORMULATION; DRUG EFFECT; HUMAN; MALE; PROSTATE; PROSTATE TUMOR; TUMOR CELL LINE;

ACRYLAMIDES; ACRYLATES; ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL SURVIVAL; CURCUMIN; DELAYED-ACTION PREPARATIONS; HUMANS; MALE; NANOPARTICLES; POLYETHYLENE GLYCOLS; PROSTATE; PROSTATIC NEOPLASMS; PYRROLIDINONES;

EID: 84884549711     PISSN: 09205063     EISSN: 15685624     Source Type: Journal    
DOI: 10.1080/09205063.2012.700111     Document Type: Article

References (56)

1. Dorai T, Cao YC, Dorai B, Buttyan R, Katz AE. Therapeutic potential of curcumin in human prostate cancer. III. Curcumin inhibits proliferation, induces apoptosis, and inhibits angiogenesis of LNCaP prostate cancer cells in vivo. Prostate. 2001;47:293-303. (Pubitemid 32521749)
2. Ringman JM, Frautschy SA, Cole GM, Masterman DL, Cummings JL. A potential role of the curry spice curcumin in Alzheimer's disease. Current Alzheimer Research. 2005;2:131-6. (Pubitemid 40862872)
3. Weber WM, Hunsaker LA, Abcouwer SF, Deck LM, Vander Jagt DL. Anti-oxidant activities of curcumin and related enones. Bioorganic & Medicinal Chemistry. 2005;13:3811-20. (Pubitemid 40615931)
4. Maheshwari RK, Singh AK, Gaddipati J, Srimal RC. Multiple biological activities of curcumin: A short review. Life Sciences. 2006;78:2081-7.
5. Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB. Bioavailability of curcumin: Problems and promises. Molecular Pharmaceutics. 2007;4:807-18.
6. Singh S, Aggarwal BB. Activation of transcription factor NF-kappa B is suppressed by curcumin (diferuloylmethane). Journal of Biological Chemistry. 1995;270:24995-5000.
7. Shishodia S, Amin HM, Lai R, Aggarwal BB. Curcumin (diferuloylmethane) inhibits constitutive NF-kappaB activation, induces Gl/S arrest, suppresses proliferation, and induces apoptosis in mantle cell lymphoma. Biochemical Pharmacology. 2005;70:700-13. (Pubitemid 41058705)
8. Menon VP, Sudheer AR. Antioxidant and anti-inflammatory properties of curcumin. Advances in Experimental Medicine and Biology. 2007;595:105-25.
9. Chen H, Zhang ZS, Zhang YL, Zhou DY. Curcumin inhibits cell proliferation by interfering with the cell cycle and inducing apoptosis in colon carcinoma cells. Anticancer Research. 1999;19:3675-80.
10. Shishodia S, Chaturvedi MM, Aggarwal BB. Role of curcumin in cancer therapy. Current Problems in Cancer. 2007;31:243-305. (Pubitemid 47077491)
11. Piper JT, Singhal SS, Salameh MS, Torman RT, Awasthi YC, Awasthi S. Mechanisms of anticarcinogenic properties of curcumin: the effect of curcumin on glutathione linked detoxification enzymes in rat liver. International Journal of Biochemistry & Cell Biology. 1998;30:445-56. (Pubitemid 28293675)
12. Watanabe S, Fukui T. Suppressive effect of curcumin on trichloroethylene-induced oxidative stress. Journal of Nutritional Science and Vitaminology 2000;46:230-4. (Pubitemid 32010159)
13. Cheng C, Wei H, Zhu JL, Chang C, Cheng H, Li C, Cheng SX, Zhang XZ, Zhuo RX. Functionalized thermoresponsive micelles self-assembled from biotin-PEG-b-P(NlPAAm-co-HMAAm)-bPMMA for tumor cell target. Bioconjugate Chemistry. 2008;19:1194-201. (Pubitemid 351874941)
14. Das RK, Kasoju N, Bora U. Encapsulation of curcumin in alginate-chitosan-pluronic composite nanoparticles for delivery to cancer cells. Nanomedicine 2010;6:153-60.
15. Garcea G, Jones DJ, Singh R, Dennison AR, Farmer PB, Sharma RA, Steward WP, Gescher AJ, Berry DP. Detection of curcumin and its metabolites in hepatic tissue and portal blood of patients following oral administration. British Journal of Cancer. 2004;90:1011-5. (Pubitemid 38499692)
16. Cheng AL, Hsu CH, Lin JK, Hsu MM, Ho YF, Shen TS, Ko JY, Lin BR, Ming-Shiang W, Yu HS, Jee SH, Chen GS, Chen TM, Chen CA, Lai MK, Pu YS, Pan MH, Wang YJ, Tsai CC, Hsieh CY. Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or premalignant lesions. Anticancer Research. 2001;21:2895-900. (Pubitemid 33051148)
17. Sharma RA, McLelland HR, Hill KA, Ireson CR, Euden SA, Manson MM, Pirmohamed M, Mamett L J, Gescher AJ, Steward WP. Pharmacodynamic and pharmacokinetic study of oral curcuma extract in patients with colorectal cancer. Clinical Cancer Research. 2001;7:1894-900. (Pubitemid 32994823)
18. Pan MH, Huang TM, Lin JK. Biotransformation of curcumin through reduction and glucuronidation in mice. Drug Metabolism and Disposition. 1999;27:486-94.
19. Ansari MJ, Ahmad S, Kohli K, Ali J, Khar RK. Stability-indicating HPTLC determination of curcumin in bulk drug and pharmaceutical formulations. Journal of Pharmaceutical and Biomedical Analysis. 2005;39:132-8. (Pubitemid 41112129)
20. Wahlang B, Pawar YB, Bansal AK. Identification of permeability-related hurdles in oral delivery of curcumin using the Caco-2 cell model. European Journal of Pharmaceutics and Biopharmaceu tics. 2011;77:275-82.
21. Asai A, Miyazawa T. Occurrence of orally administered curcuminoid as glucuronide and glucuronide/sulfate conjugates in rat plasma. Life Sciences. 2000;67:2785-93.
22. Kumar V, Lewis SA, Mutalik S, Shenoy DB, Venkatesh Udupa N. Biodegradable microspheres of curcumin for treatment of inflammation. Indian Journal of Physiology and Pharmacology. 2002;46:209-17. (Pubitemid 34415120)
23. Vemula PK, Li J, John G. Enzyme catalysis: tool to make and break amygdalin hydrogelators from renewable resources: a delivery model for hydrophobic drugs. Journal of the American Chemical Society. 2006;128:8932-8. (Pubitemid 44061551)
24. Sou K, Inenaga S, Takeoka S, Tsuchida E. Loading of curcumin into macrophages using lipidbased nanoparticles. International Journal of Pharmaceutics. 2008;352:287-93.
25. Duan J, Zhang Y, Han S, Chen Y, Li B, Liao M, Chen W, Deng X, Zhao J, Huang B. Synthesis and in vitro/in vivo anti-cancer evaluation of curcumin-loaded chitosan/poly(butyl cyanoacrylate) nanoparticles. International Journal of Pharmaceutics. 2010;400:211-20.
26. Cartiera MS, Ferreira EC, Caputo C, Egan ME, Caplan MJ, Saltzman WM. Partial correction of cystic fibrosis defects with PLGA nanoparticles encapsulating curcumin. Molecular Pharmaceutics. 2010;7:86-93.
27. Duarte VM, Han E, Veena MS, Salvado A, Suh JD, Liang LJ, Faull KF, Srivatsan ES, Wang MB. Curcumin enhances the effect of cisplatin in suppression of head and neck squamous cell carcinoma via inhibition of IKKbeta protein of the NFkappaB pathway. Molecular Cancer Therapeutics. 2010;9:2665-75.
28. Shaikh J, Ankola DD, Beniwal V, Singh D, Kumar MN. Nanoparticle encapsulation improves oral bioavailability of curcumin by at least 9-fold when compared to curcumin administered with piperine as absorption enhancer. European Journal of Pharmaceutical Sciences. 2009;37:223-30.
29. Anand P, Nair HB, Sung B, Kunnumakkara AB, Yadav VR, Tekmal RR, Aggarwal BB. Design of curcumin-loaded PLGA nanoparticles formulation with enhanced cellular uptake, and increased bioactivity in vitro and superior bioavailability in vivo. Biochemical Pharmacology. 2010;79:330-8.
30. Grabovac V, Bemkop-Schnurch A. Development and in vitro evaluation of surface modified poly (lactide-co-glycolide) nanoparticles with chitosan-4-thiobutylamidine. Drug Development and Industrial Pharmacy. 2007;33:767-74. (Pubitemid 47123803)
31. Bisht S, Feldmann G, Soni S, Ravi R, Karikar C, Maitra A, Maitra A. Polymeric nanoparticleencapsulated curcumin ('nanocurcumin'): A novel strategy for human cancer therapy. Journal of Nanobiotechnology 2007;5:3.
32. Bisht S, Mizuma M, Feldmann G, Ottenhof NA, Hong SM, Pramanik D, Chenna V, Karikari C, Sharma R, Goggins MG, Rudek MA, Ravi R, Maitra A, Maitra A. Systemic administration of polymeric nanoparticle-encapsulated curcumin (NanoCurc) blocks tumor growth and metastases in preclinical models of pancreatic cancer. Molecular Cancer Therapeutics. 2010;9:2255-64.
33. Bisht S, Khan MA, Bekhit M, Bai H, Cornish T, Minima M, Rudek MA, Zhao M, Maitra A, Ray B, Lahiri D, Maitra A, Anders RA. A polymeric nanoparticle formulation of curcumin (NanoCurc) ameliorates CC14-induced hepatic injury and fibrosis through reduction of pro-inflammatory cytokines and stellate cell activation. Laboratory Investigation. 2011;91:1383-95.
34. Ray B, Bisht S, Maitra A, Maitra A, Lahiri DK. Neuroprotective and neurorescue effects of a novel polymeric nanoparticle formulation of curcumin (NanoCurc (TM)) in the neuronal cell culture and animal model: implications for Alzheimer's disease. Journal of Alzheimer's Disease. 2011;23:61-77.
35. Rejinold NS, Sreerekha PR, Chennazhi KP, Nair SV, Jayakumar R. Biocompatible biodegradable and thermo-sensitive chitosan-g-poly (N-isopropylacrylamide) nanocarrier for curcumin drug delivery. International Journal of Biological Macromolecules. 2011;49:161-72.
36. Rejinold NS, Muthunarayanan M, Divyarani VV, Sreerekha PR, Chennazhi KP, Nair SV, Tamura H, Jayakumar R. Curcumin-loaded biocompatible thermoresponsive polymeric nanoparticles for cancer drug delivery. Journal of Colloid and Interface Science. 2011;360:39-51.
37. Mulik R, Mahadik K, Paradkar A. Development of curcuminoids loaded poly(butyl) cyanoacrylate nanoparticles: Physicochemical characterization and stability study. European Journal of Pharma ceutical Sciences. 2009;37:395-404.
38. Yan C, Elaissari A, Pichot C. Loading and release studies of proteins using poly(N-isopropylacrylamide) based nanogels. Journal of Biomedical Nanotechnology 2006;2:208-16.
39. Mahaijan P, Woonton BW, Bennett LE, Smithers GW, DeSilva K, Hearn MTW. Novel chromatographic separation - the potential of smart polymers. Innovative Food Science and Emerging Technologies. 2008;9:232-42. (Pubitemid 351215970)
40. Malmstadt N, Yager P, Hoffman AS, Stayton PS. A smart microfluidic affinity chromatography matrix composed of poly(N-isopropylacrylamide)-coated beads. Analytical Chemistry. 2003;75:2943-9. (Pubitemid 36830419)
41. Cheng V, Lee BH, Pauken C, Vernon BL. Poly(N-isopropylacrylamide-co- poly(ethylene glycol))acrylate simultaneously physically and chemically gelling polymer systems. Journal of Applied Polymer Science. 2007;106:1201-7. (Pubitemid 47384101)
42. Dincer S, Rzaev ZMO, Piskin E. Synthesis and characterization of stimuli-responsive poly(N-isopropylacrylamide-co-N-vinyl-2-pyrrolidone). Journal of Polymer Research. 2006;13:121-31.
43. Güven O, Sen M. Preparation and characterization of poly(n-vinyl 2-pyrrolidone) hydrogels. Poly mer. 1991;32:2491-5. (Pubitemid 21708722)
44. Vakkalanka SK, Brazel CS, Peppas NA. Temperature- and pH-sensitive terpolymers for modulated delivery of streptokinase. Journal of Biomaterials Science, Polymer Edition. 1996;8:119-29. (Pubitemid 26402045)
45. Chilkoti A, Dreher MR, Meyer DE, Raucher D. Targeted drug delivery by thermally responsive polymers. Advanced Drug Delivery Reviews. 2002;54:613-30. (Pubitemid 35247519)
46. Medeiros SF, Santos AM, Fessi H, Elaissari A. Synthesis of biocompatible and thermally sensitive poly(N-vinylcaprolactam) nanogels via inverse miniemulsion polymerization: Effect of the surfactant concentration. Polymer Chemistry. 2010;48:3932-41.
47. Tyagi R, Lala S, Verma AK, Nandy AK, Mahato SB, Maitra A, Basu MK. Targeted delivery of arjunglucoside I using surface hydrophilic and hydrophobic nanocarriers to combat experimental leishmaniasis. Journal of Drug Targeting. 2005;13:161-71. (Pubitemid 40668169)
48. Soni S, Babbar AK, Sharma RK, Maitra A. Delivery of hydrophobised 5-fluorouracil derivative to brain tissue through intravenous route using surface modified nanogels. Journal of Drug Targeting. 2006;14:87-95.
49. Wang YJ, Pan MH, Cheng AL, Lin LI, Ho YS, Hsieh CY, Lin JK. Stability of curcumin in buffer solutions and characterization of its degradation products. Journal of Pharmaceutical and Biomedi cal Analysis. 1997 15:1867-76.
50. Mohanty C, Sahoo SK. The in vitro stability and in vivo pharmacokinetics of curcumin prepared as an aqueous nanoparticulate formulation. Biomaterials 2010;31:6597-611.
51. Shoba G, Joy D, Joseph T, Majeed M, Rajendran R, Srinivas PS. Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. Planta Medica 1998;64:353-6. (Pubitemid 28234275)
52. Ireson CR, Jones DL, Orr S, Coughtrie MW, Boocock DJ, Williams ML, Farmer PB, Steward WP, Gescher AJ. Metabolism of the cancer chemopreventive agent curcumin in human and rat intestine. Cancer Epidemiology Biomarkers & Prevention. 2002;11:105-11. (Pubitemid 34118319)
53. Sahu A, Bora U, Kasoju N, Goswami P. Synthesis of novel biodegradable and self-assembling methoxy poly(ethylene glycol)-palmitate nanocarrier for curcumin delivery to cancer cells. Acta Biomaterialia 2008;4:1752-61.
54. McGowan EM, Ailing N, Jackson EA, Yagoub D, Haass NK, Allen JD, Martinello-Wilks R. Eval uation of cell cycle arrest in estrogen responsive MCF-7 breast cancer cells: Pitfalls of the MTS assay. PLoS ONE. 2011;6:e20623.
55. Baisch H. Relationship between cell kinetics and apoptotic effects in TNF-alpha and IFN-gammatreated human tumour cell lines. European Cytokine Network. 2001;12:604-13. (Pubitemid 34062147)
56. Lim KJ, Bisht S, Bar EE, Maitra A, Eberhart CG. A polymeric nanoparticle formulation of curcumin inhibits growth, clonogenicity and stem-like fraction in malignant brain tumors. Cancer Biology & Therapy. 2011 11:464-73.